SCHEMBL1346468

SCHEMBL1346468

CCOC(=O)C(C)C(Cc1ccc(OC)cc1)c1ccc(OC)c(C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAS1R3 Q7RTX0 2/20 0.47
▸ TAS1R1 Q7RTX1 2/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ ALDH1A1 P00352 4/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ EPHX2 P34913 1/20 0.42
▸ LDHA P00338 1/20 0.42
▸ CYP3A4 P08684 2/20 0.40
▸ SLC6A2 P23975 2/20 0.40
▸ SLC6A4 P31645 2/20 0.40
▸ SLC6A3 Q01959 2/20 0.40
▸ CYP2D6 P10635 2/20 0.40
▸ ADRB2 P07550 1/20 0.40
▸ HTR1A P08908 1/20 0.40
▸ ADRA2A P08913 1/20 0.40
▸ CHRM1 P11229 1/20 0.40
▸ DRD2 P14416 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ ADRA2B P18089 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1347512 0.88 EPHX2 (0.51) ALDH1A1KMT2AMEN1EPHX2LDHA
SCHEMBL1346076 0.84 TAS2R14 (0.46) TAS1R3TAS1R1ALDH1A1KMT2AMEN1
SCHEMBL1345038 0.76 LDHA (0.42) TAS1R3TAS1R1ALDH1A1EPHX2LDHA
SCHEMBL11764494 0.75 ALOX15 (0.51) ALDH1A1KMT2AMEN1LMNAMAPT
SCHEMBL1344851 0.74 EPHX2 (0.53) L3MBTL1ALDH1A1KMT2AMEN1EPHX2
SCHEMBL11762033 0.72 LDHA (0.57) ALDH1A1KMT2AMEN1EPHX2LDHA
SCHEMBL1346136 0.72 EPHX2 (0.48) TAS1R3TAS1R1L3MBTL1ALDH1A1KMT2A
SCHEMBL490486 0.71 LDHA (0.69) L3MBTL1ALDH1A1KMT2AMEN1EPHX2
SCHEMBL14874407 0.70 MMP8 (0.47) L3MBTL1ALDH1A1KMT2AMEN1EPHX2
SCHEMBL2241047 0.70 LDHA (0.57) ALDH1A1KMT2AMEN1EPHX2LDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406206-B1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES MSD OSS BV (NL) 2013-01-30 — — EP disclosed
EP-2406206-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES MSD Oss B.V. (NL) 2012-01-18 — — EP disclosed
US-8063102-B2 Tetrahydronaphthalen-2-ol derivatives N.V. ORGANON (NL) 2011-11-22 — — US disclosed
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES N. V. ORGANON 2010-09-23 — — US disclosed
WO-2010103095-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES N.V. ORGANON (NL) 2010-09-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES VHL, BRCA1, TPH2 TAS1R3 2433/4885TAS1R1 2561/4885L3MBTL1 3727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback